Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: why not this

why not this

posted on Dec 04, 2007 01:35PM

Infringing companies pay for licensing fee.  JT accumulates cash to 100 million or more.  Invested, this makes at least 8% or 8 million a year.  Using this, JT makes acquisitions.  We become a conglomerate.  We have annual income.  We get listed somewhere better than BB.  If we can dream it, can JT build it?  This could be soooooo sweet.


Dec 04, 2007 01:40PM
Share
New Message
Please login to post a reply